Can Tc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?
作者信息
Haq Muhammad, Pawar Sumeet, Berk John L, Miller Edward J, Ruberg Frederick L
出版信息
JACC Cardiovasc Imaging. 2017 Jun;10(6):713-714. doi: 10.1016/j.jcmg.2016.06.003. Epub 2016 Aug 24.
Abstract
摘要
相似文献
1
Can Tc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?
JACC Cardiovasc Imaging. 2017 Jun;10(6):713-714. doi: 10.1016/j.jcmg.2016.06.003. Epub 2016 Aug 24.
2
Combination of Commonly Examined Parameters Is a Useful Predictor of Positive Tc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis.
Circ J. 2019 Jul 25;83(8):1698-1708. doi: 10.1253/circj.CJ-19-0255. Epub 2019 Jun 13.
3
Early Phase Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis.
JACC Cardiovasc Imaging. 2017 May;10(5):601-603. doi: 10.1016/j.jcmg.2016.05.007. Epub 2016 Jul 13.
4
Cardiac scintigraphy with Tc-diphosphonates in cardiac amyloidosis.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jul-Aug;39(4):254-266. doi: 10.1016/j.remn.2020.03.007. Epub 2020 Jun 6.
5
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
JACC Cardiovasc Imaging. 2020 Jun;13(6):1314-1321. doi: 10.1016/j.jcmg.2019.10.015. Epub 2019 Dec 18.
6
(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):195-201. doi: 10.1161/CIRCIMAGING.112.000132. Epub 2013 Feb 11.
7
Non-invasive detection and differentiation of cardiac amyloidosis using Tc-pyrophosphate scintigraphy and C-Pittsburgh compound B PET imaging.
Amyloid. 2020 Dec;27(4):266-274. doi: 10.1080/13506129.2020.1798223. Epub 2020 Jul 28.
8
Transthyretin Amyloid Cardiomyopathy Diagnosed on Incidental Myocardial Uptake During Bone Scintigraphy.
Circ J. 2020 Mar 25;84(4):679. doi: 10.1253/circj.CJ-19-1155. Epub 2020 Mar 4.
9
Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
Amyloid. 2012 Mar;19(1):41-6. doi: 10.3109/13506129.2011.638682. Epub 2011 Dec 8.
10
Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up?
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):162-4. doi: 10.1161/CIRCIMAGING.113.000178.
引用本文的文献
1
Screening for Cardiac Amyloidosis When Conducting Carpal Tunnel Surgery.
J Clin Med. 2025 May 26;14(11):3710. doi: 10.3390/jcm14113710.
2
Diagnosis and Management of Mixed Phenotype Hereditary Transthyretin Amyloidosis: A Case-Based, Canadian Perspective.
CJC Open. 2025 Mar 10;7(5):614-627. doi: 10.1016/j.cjco.2025.03.002. eCollection 2025 May.
3
Tafamidis therapy in transthyretin amyloid cardiomyopathy: a narrative review from clinical trials and real-world evidence.
Egypt Heart J. 2024 Jul 10;76(1):90. doi: 10.1186/s43044-024-00517-y.
4
Scintigraphic and Echocardiographic Study of Patients with Pathogenic or Probably Pathogenic Variants of the TTR Gene without Overt Cardiac Involvement.
Arq Bras Cardiol. 2024 May 20;121(4):e20230216. doi: 10.36660/abc.20230216. eCollection 2024.
5
High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients.
J Clin Med. 2024 Jan 30;13(3):810. doi: 10.3390/jcm13030810.
6
Performance of Tc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis.
Ann Nucl Med. 2024 Apr;38(4):288-295. doi: 10.1007/s12149-023-01898-x. Epub 2024 Jan 22.
7
Multimodality imaging of cardiac amyloidosis.
Heart. 2024 May 23;110(12):873-882. doi: 10.1136/heartjnl-2022-321115.
8
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.
Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.
9
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
Circ Cardiovasc Imaging. 2022 Nov;15(11):e014645. doi: 10.1161/CIRCIMAGING.122.014645. Epub 2022 Nov 15.
10
Diagnostic Value of C-PIB PET/MR in Cardiac Amyloidosis.
Front Cardiovasc Med. 2022 Mar 16;9:830572. doi: 10.3389/fcvm.2022.830572. eCollection 2022.
本文引用的文献
1
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.
2
Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.
JACC Heart Fail. 2014 Apr;2(2):113-22. doi: 10.1016/j.jchf.2013.11.004.
3
(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):195-201. doi: 10.1161/CIRCIMAGING.112.000132. Epub 2013 Feb 11.
4
Tabulation of human transthyretin (TTR) variants, 2003.
Amyloid. 2003 Sep;10(3):160-84. doi: 10.3109/13506120308998998.
Zotero 插件